Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00836680
Other study ID # GPejcl-230109
Secondary ID
Status Recruiting
Phase N/A
First received January 23, 2009
Last updated February 2, 2009
Start date January 2009
Est. completion date June 2009

Study information

Verified date February 2009
Source Gerhard Pejcl Medizintechnik GmbH
Contact Michaela Abrahamowicz, Dr. med.
Phone 01143 6607668922
Email info@auau.at
Is FDA regulated No
Health authority Austria: Federal Ministry for Health and Women
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if the device is supplying sufficient diagnosis results of an internal rectal prolapse, of a pelvic floor ptosis and for the determination of an interal hernia into the Douglas pouch, as well as to determine the technical success of using the device at the patient.


Description:

Existing diagnosis methods are inadequate, inaccurate, complicated or can only made intraoperatively. The new device should enable a fast and easy examination procedure well tolerated by the patients. The diagnosis results, received with the device, should assist in the accurate selection of patients for operations as well as to avoid any unnecessary operations.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date June 2009
Est. primary completion date May 2009
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- female patients

- patients with ODS-Symptome-Score according Longo of >7

- existing results about a perceptible and seeable internal rectal prolapse, pelvic floor ptosis and an internal hernia into the Douglas pouch

- patients who correspond to to the ASA 1 - ASA 2 criteria

Exclusion Criteria:

- male patients

- female patients with inflammable or malign diseases of the urogenital tract as well as of the anorectal area and after rectum operation

- female patients with diarrhea

- pregnant patients because of the x-ray examination

- female patients who get anticoagulants

- serious cardiopulmonary disorders

- disorders of the blood coagulation

- female patients who correspond to the ASA 3 to ASA 4 criteria

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Colorectal Stent
Diagnosis of an internal rectal prolapse: The device will be introduced and placed into the patient via a proctoscopic procedure. After that the doctor can measure and determine the internal rectal prolapse. After the diagnosis results have been received, the device will be removed from the patient via proctoscopic examination. The whole procedure will take approx. 5 minutes. An additional X-ray examination procedure with the use of contrast media will be made for the determination of a pelvic floor ptosis and for the determination of an internal hernia into the Douglas pouch.

Locations

Country Name City State
Austria St. Elisabeth Hospital Vienna

Sponsors (1)

Lead Sponsor Collaborator
Gerhard Pejcl Medizintechnik GmbH

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determination if the device will be effective for the diagnosis of an internal rectal prolapse, a pelvic floor ptosis and for the determination of an internal hernia into the Douglas pouch. 4 months Yes
Secondary Determination if the the use of the device will be tolerated by the patient combined with a low level of pain or discomfort. 4 months Yes